BridgeBio Pharma, Inc. - Common Stock (BBIO) stock analysis

BBIO · BridgeBio Pharma, Inc. - Common Stock

Latest recorded price: USD 77.36

Sector and industry: Healthcare · Biotechnology

Fiscal 2025 figures: revenue growth 86.3%, free cash flow margin -89.0%. The model flags 2 risk signals for this company (1 high severity).

Similar companies in Healthcare